{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:32:06Z","timestamp":1774614726715,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s11938-016-0094-y","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T06:08:57Z","timestamp":1459490937000},"page":"274-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Changing Role of Sodium Management in Cirrhosis"],"prefix":"10.1007","volume":"14","author":[{"given":"Blanca","family":"Lizaola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Bonder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot B.","family":"Tapper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Mendez-Bocanegra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Cardenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"issue":"6","key":"94_CR1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.21412","volume":"44","author":"P Angeli","year":"2006","unstructured":"Angeli P et al. Hyponatremia in cirrhosis: results of a patient population survey. Hepatology. 2006;44(6):1535\u201342.","journal-title":"Hepatology"},{"issue":"3","key":"94_CR2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510280337","volume":"28","author":"P Gines","year":"1998","unstructured":"Gines P et al. Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology. 1998;28(3):851\u201364.","journal-title":"Hepatology"},{"issue":"5","key":"94_CR3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/j.ajkd.2014.06.001","volume":"64","author":"HJ Adrogue","year":"2014","unstructured":"Adrogue HJ, Madias NE. Diagnosis and treatment of hyponatremia. Am J Kidney Dis. 2014;64(5):681\u20134.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"94_CR4","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/hep.22418","volume":"48","author":"P Gines","year":"2008","unstructured":"Gines P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008;48(3):1002\u201310.","journal-title":"Hepatology"},{"issue":"11","key":"94_CR5","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.3748\/wjg.v21.i11.3197","volume":"21","author":"S John","year":"2015","unstructured":"John S, Thuluvath PJ. Hyponatremia in cirrhosis: pathophysiology and management. World J Gastroenterol. 2015;21(11):3197\u2013205.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"94_CR6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.20517","volume":"41","author":"SW Biggins","year":"2005","unstructured":"Biggins SW et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005;41(1):32\u20139.","journal-title":"Hepatology"},{"issue":"1","key":"94_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","volume":"105","author":"A Gines","year":"1993","unstructured":"Gines A et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. 1993;105(1):229\u201336.","journal-title":"Gastroenterology"},{"issue":"6","key":"94_CR8","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jhep.2012.07.020","volume":"57","author":"E Sola","year":"2012","unstructured":"Sola E et al. Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. J Hepatol. 2012;57(6):1199\u2013206.","journal-title":"J Hepatol"},{"issue":"5","key":"94_CR9","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hep.22846","volume":"49","author":"BC Yun","year":"2009","unstructured":"Yun BC et al. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology. 2009;49(5):1610\u20135.","journal-title":"Hepatology"},{"issue":"4","key":"94_CR10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1053\/j.gastro.2006.02.017","volume":"130","author":"MC Londono","year":"2006","unstructured":"Londono MC et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology. 2006;130(4):1135\u201343.","journal-title":"Gastroenterology"},{"issue":"4","key":"94_CR11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840400409","volume":"40","author":"DM Heuman","year":"2004","unstructured":"Heuman DM et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004;40(4):802\u201310.","journal-title":"Hepatology"},{"issue":"10","key":"94_CR12","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","volume":"359","author":"WR Kim","year":"2008","unstructured":"Kim WR et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359(10):1018\u201326.","journal-title":"N Engl J Med"},{"issue":"6","key":"94_CR13","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","volume":"130","author":"SW Biggins","year":"2006","unstructured":"Biggins SW et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130(6):1652\u201360.","journal-title":"Gastroenterology"},{"issue":"3","key":"94_CR14","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/lt.20329","volume":"11","author":"AE Ruf","year":"2005","unstructured":"Ruf AE et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl. 2005;11(3):336\u201343.","journal-title":"Liver Transpl"},{"issue":"5","key":"94_CR15","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0016-5085(89)91704-6","volume":"97","author":"J Fernandez-Seara","year":"1989","unstructured":"Fernandez-Seara J et al. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology. 1989;97(5):1304\u201312.","journal-title":"Gastroenterology"},{"issue":"6","key":"94_CR16","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/hep.21414","volume":"44","author":"C Esteva-Font","year":"2006","unstructured":"Esteva-Font C et al. Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: relationship with ascites and hepatorenal syndrome. Hepatology. 2006;44(6):1555\u201363.","journal-title":"Hepatology"},{"issue":"5","key":"94_CR17","first-page":"788","volume":"17","author":"A Maroto","year":"1993","unstructured":"Maroto A et al. Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction. Hepatology. 1993;17(5):788\u201393.","journal-title":"Hepatology"},{"issue":"8744","key":"94_CR18","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0140-6736(91)91384-7","volume":"337","author":"P Vallance","year":"1991","unstructured":"Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet. 1991;337(8744):776\u20138.","journal-title":"Lancet"},{"issue":"7 Suppl 1","key":"94_CR19","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.amjmed.2006.05.007","volume":"119","author":"RW Schrier","year":"2006","unstructured":"Schrier RW. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med. 2006;119(7 Suppl 1):S47\u201353.","journal-title":"Am J Med"},{"issue":"1","key":"94_CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2008-1040320","volume":"28","author":"P Gines","year":"2008","unstructured":"Gines P, Cardenas A. The management of ascites and hyponatremia in cirrhosis. Semin Liver Dis. 2008;28(1):43\u201358.","journal-title":"Semin Liver Dis"},{"issue":"Suppl 3","key":"94_CR21","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1097\/MCG.0b013e3181468b4c","volume":"41","author":"Y Iwakiri","year":"2007","unstructured":"Iwakiri Y. The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension. J Clin Gastroenterol. 2007;41 Suppl 3:S288\u201394.","journal-title":"J Clin Gastroenterol"},{"key":"94_CR22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-4615-4871-3_34","volume":"449","author":"M Thibonnier","year":"1998","unstructured":"Thibonnier M et al. Molecular pharmacology of human vasopressin receptors. Adv Exp Med Biol. 1998;449:251\u201376.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"94_CR23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/snep.2001.21647","volume":"21","author":"TH Kwon","year":"2001","unstructured":"Kwon TH et al. Physiology and pathophysiology of renal aquaporins. Semin Nephrol. 2001;21(3):231\u20138.","journal-title":"Semin Nephrol"},{"issue":"1","key":"94_CR24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1152\/physrev.00024.2001","volume":"82","author":"S Nielsen","year":"2002","unstructured":"Nielsen S et al. Aquaporins in the kidney: from molecules to medicine. Physiol Rev. 2002;82(1):205\u201344.","journal-title":"Physiol Rev"},{"issue":"24","key":"94_CR25","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJM198606123142402","volume":"314","author":"RH Sterns","year":"1986","unstructured":"Sterns RH, Riggs JE, Schochet Jr SS. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med. 1986;314(24):1535\u201342.","journal-title":"N Engl J Med"},{"issue":"8","key":"94_CR26","first-page":"349","volume":"55","author":"RS Tanneau","year":"1994","unstructured":"Tanneau RS et al. High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients. J Clin Psychiatry. 1994;55(8):349\u201354.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"94_CR27","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/ajg.2009.293","volume":"104","author":"M Guevara","year":"2009","unstructured":"Guevara M et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol. 2009;104(6):1382\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"94_CR28","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/j.1572-0241.2008.02102.x","volume":"103","author":"O Riggio","year":"2008","unstructured":"Riggio O et al. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol. 2008;103(11):2738\u201346.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"94_CR29","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1478-3231.2010.02293.x","volume":"30","author":"M Guevara","year":"2010","unstructured":"Guevara M et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int. 2010;30(8):1137\u201342.","journal-title":"Liver Int"},{"issue":"9","key":"94_CR30","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/liv.12795","volume":"35","author":"P Schwabl","year":"2015","unstructured":"Schwabl P et al. Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites. Liver Int. 2015;35(9):2121\u20138. Retrospective cohort study demonstrating that hyponatremia along with Child-Pugh stage C and elevated ascites represent predictive factors for SBP development and higher mortality in patients with liver cirrhosis.","journal-title":"Liver Int"},{"issue":"1","key":"94_CR31","first-page":"142","volume":"32","author":"A Rimola","year":"2000","unstructured":"Rimola A et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. Int Ascites Club J Hepatol. 2000;32(1):142\u201353.","journal-title":"Int Ascites Club J Hepatol"},{"issue":"4","key":"94_CR32","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","volume":"139","author":"V Arvaniti","year":"2010","unstructured":"Arvaniti V et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139(4):1246\u201356. 1256.e1\u20135.","journal-title":"Gastroenterology"},{"key":"94_CR33","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3): 397\u2013417.","DOI":"10.1016\/j.jhep.2010.05.004"},{"issue":"3","key":"94_CR34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-1007240","volume":"16","author":"J Cordoba","year":"1996","unstructured":"Cordoba J, Blei AT. Brain edema and hepatic encephalopathy. Semin Liver Dis. 1996;16(3):271\u201380.","journal-title":"Semin Liver Dis"},{"issue":"4","key":"94_CR35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0168-8278(99)80361-4","volume":"31","author":"AT Blei","year":"1999","unstructured":"Blei AT, Larsen FS. Pathophysiology of cerebral edema in fulminant hepatic failure. J Hepatol. 1999;31(4):771\u20136.","journal-title":"J Hepatol"},{"issue":"6","key":"94_CR36","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0168-8278(00)80110-5","volume":"32","author":"D Haussinger","year":"2000","unstructured":"Haussinger D et al. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol. 2000;32(6):1035\u20138.","journal-title":"J Hepatol"},{"key":"94_CR37","doi-asserted-by":"crossref","unstructured":"Butterworth RF. Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies. J Hepatol. 2003;39(2):278\u201385.","DOI":"10.1016\/S0168-8278(03)00267-8"},{"issue":"2","key":"94_CR38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1172\/JCI117728","volume":"95","author":"JS Videen","year":"1995","unstructured":"Videen JS et al. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. J Clin Invest. 1995;95(2):788\u201393.","journal-title":"J Clin Invest"},{"issue":"6","key":"94_CR39","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/01.ASN.0000017903.77985.CD","volume":"13","author":"A Soupart","year":"2002","unstructured":"Soupart A et al. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. J Am Soc Nephrol. 2002;13(6):1433\u201341.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"94_CR40","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0016-5085(97)70043-X","volume":"112","author":"J Laubenberger","year":"1997","unstructured":"Laubenberger J et al. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology. 1997;112(5):1610\u20136.","journal-title":"Gastroenterology"},{"issue":"6","key":"94_CR41","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/hep.20237","volume":"39","author":"T Restuccia","year":"2004","unstructured":"Restuccia T et al. Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis. Hepatology. 2004;39(6):1613\u201322.","journal-title":"Hepatology"},{"issue":"4","key":"94_CR42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9629(15)40736-0","volume":"319","author":"H Furst","year":"2000","unstructured":"Furst H et al. The urine\/plasma electrolyte ratio: a predictive guide to water restriction. Am J Med Sci. 2000;319(4):240\u20134.","journal-title":"Am J Med Sci"},{"issue":"2","key":"94_CR43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/gut.31.2.204","volume":"31","author":"PA McCormick","year":"1990","unstructured":"McCormick PA et al. Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites. Gut. 1990;31(2):204\u20137.","journal-title":"Gut"},{"issue":"3","key":"94_CR44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1399-0012.1998.tb01102.x","volume":"12","author":"O Abbasoglu","year":"1998","unstructured":"Abbasoglu O et al. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transpl. 1998;12(3):263\u20139.","journal-title":"Clin Transpl"},{"issue":"9624","key":"94_CR45","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0140-6736(08)60695-9","volume":"371","author":"G Decaux","year":"2008","unstructured":"Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet. 2008;371(9624):1624\u201332.","journal-title":"Lancet"},{"issue":"1","key":"94_CR46","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jhep.2003.50021","volume":"37","author":"F Wong","year":"2003","unstructured":"Wong F et al. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Hepatology. 2003;37(1):182\u201391.","journal-title":"Hepatology"},{"issue":"4","key":"94_CR47","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/gast.2003.50143","volume":"124","author":"AL Gerbes","year":"2003","unstructured":"Gerbes AL et al. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology. 2003;124(4):933\u20139.","journal-title":"Gastroenterology"},{"issue":"20","key":"94_CR48","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","volume":"355","author":"RW Schrier","year":"2006","unstructured":"Schrier RW et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355(20):2099\u2013112.","journal-title":"N Engl J Med"},{"issue":"1","key":"94_CR49","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.22293","volume":"48","author":"P Gines","year":"2008","unstructured":"Gines P et al. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology. 2008;48(1):204\u201313.","journal-title":"Hepatology"},{"issue":"3","key":"94_CR50","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2011.08.020","volume":"56","author":"A Cardenas","year":"2012","unstructured":"Cardenas A et al. Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis. J Hepatol. 2012;56(3):571\u20138. Sub-analysis of the Study of Ascending Levels of Tolvaptan trials, comparing tolvaptan treatment against placebo exclusively in cirrhotic patients with hyponatremia. The results demonstrated that tolvaptan in addition to standard therapy, effectively raises and maintains serum sodium concentrations and improves health-related quality of life.","journal-title":"J Hepatol"},{"issue":"10","key":"94_CR51","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/lt.21836","volume":"15","author":"JG O\u2019Leary","year":"2009","unstructured":"O\u2019Leary JG, Davis GL. Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease. Liver Transpl. 2009;15(10):1325\u20139.","journal-title":"Liver Transpl"},{"key":"94_CR52","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367:2407\u201318.","journal-title":"N Engl J Med"},{"key":"94_CR53","unstructured":"Samsca (Tolvaptan): Drug safety communication\u2014FDA limits duration and usage due to possible liver injury leading to organ transplant or death. http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm350185.htm ."},{"issue":"1","key":"94_CR54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jhep.2014.09.028","volume":"62","author":"A C\u00e1rdenas","year":"2015","unstructured":"C\u00e1rdenas A, Riggio O. Correction of hyponatraemia in cirrhosis: treating more than a number! J Hepatol. 2015;62(1):13\u20134.","journal-title":"J Hepatol"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-016-0094-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-016-0094-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-016-0094-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T02:19:55Z","timestamp":1748830795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-016-0094-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["94"],"URL":"https:\/\/doi.org\/10.1007\/s11938-016-0094-y","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]}}}